Thyroid hormone receptor 3D structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) New page: Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} - For a general description of the protein see Thymidylate kinase {{#tree:id=OrganizedByTopic|openlevels=0|... |
Michal Harel (talk | contribs) No edit summary |
||
| Line 22: | Line 22: | ||
**[[4zo1]] – hTR b1 LBD + retinoic acid receptor + NCOA2 peptide + triiodo-thyronine <br /> | **[[4zo1]] – hTR b1 LBD + retinoic acid receptor + NCOA2 peptide + triiodo-thyronine <br /> | ||
**[[7wlx]], [[7wmg]], [[7wmh]], [[7wmj]], [[7wml]], [[7wmn]], [[7wmo]] – hTR b1 LBD + NCOA2 peptide + quinoline derivative <br /> | **[[7wlx]], [[7wmg]], [[7wmh]], [[7wmj]], [[7wml]], [[7wmn]], [[7wmo]] – hTR b1 LBD + NCOA2 peptide + quinoline derivative <br /> | ||
**[[6knw]], [[6knu]], [[6knv]] – hTR b1 LBD (mutant) + NCOA2 peptide + quinoline derivative <br /> | |||
**[[6kkb]] – hTR b1 LBD + SRC2-3 + quinoline derivative <br /> | **[[6kkb]] – hTR b1 LBD + SRC2-3 + quinoline derivative <br /> | ||
**[[6kkc]] – hTR b1 LBD (mutant) + SRC2-3 + quinoline derivative <br /> | **[[6kkc]] – hTR b1 LBD (mutant) + SRC2-3 + quinoline derivative <br /> | ||
Revision as of 12:46, 25 December 2023
Updated on 25-December-2023 - For a general description of the protein see Thymidylate kinase